MYC and acute promyelocytic leukemia: On the other hand, ATRA alone, which is a standard drug used for differentiation therapy in APL, inhibited cell growth to approximately 20% that of control cells, suppressed c-MYC expression to <10% that of control cells, and markedly induced cyclin G2 gene expression (6.9-fold) (Fig. 8).